Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Anosmia: A Missing Link in the Neuroimmunology of Coronavirus Disease 2019 (Covid-19) Publisher Pubmed



Yazdanpanah N1, 4 ; Saghazadeh A1, 5 ; Rezaei N1, 2, 3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Research Center for Immunodeficiencies, Tehran University of Medical Sciences, Children's Medical Center, Dr. Qarib St, Keshavarz Blvd, Tehran, 14194, Iran
  2. 2. Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, 14194, Iran
  3. 3. Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, 14194, Iran
  4. 4. Systematic Review and Meta-analysis Expert Group (SRMEG), Universal Scientific Education and Research Network (USERN), Tehran, 14194, Iran
  5. 5. NeuroImmunology Research Association (NIRA), Universal Scientific Education and Research Network (USERN), Tehran, 14194, Iran

Source: Reviews in the Neurosciences Published:2020


Abstract

Just before 2020 began, a novel coronavirus, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), brought for humans a potentially fatal disease known as coronavirus disease 2019 (COVID-19). The world has thoroughly been affected by COVID-19, while there has been little progress towards understanding the pathogenesis of COVID-19. Patients with a severe phenotype of disease and those who died fromthe disease have shown hyperinflammation and were more likely to develop neurological manifestations, linking the clinical disease with neuroimmunological features. Anosmia frequently occurs early in the course of COVID-19. The prevalence of anosmia would be influenced by selfdiagnosis as well as self-misdiagnosis in patients with COVID-19. Despite this, the association between anosmia and COVID-19 has been a hope for research, aiming to understand the pathogenesis of COVID-19. Studies have suggested differently probable mechanisms for the development of anosmia in COVID-19, including olfactory cleft syndrome, postviral anosmia syndrome, cytokinestorm, direct damage of olfactory sensory neurons, and impairment of the olfactory perception center in the brain. Thus, the observation of anosmia would direct us to find the pathogenesis of COVID-19 in the central nervous system, and this is consistent with numerous neurological manifestations related to COVID-19. Like other neurotropic viruses, SARS-CoV-2might be able to enter the central nervous system via the olfactory epithelium and induce innate immune responses at the site of entry. Viral replication in the nonneural olfactory cells indirectly causes damage to the olfactory receptor nerves, and as a consequence, anosmia occurs. Further studies are required to investigate the neuroimmunology of COVID-19 in relation to anosmia. © 2020 De Gruyter. All rights reserved.
Other Related Docs
10. Introduction on Coronavirus Disease (Covid-19) Pandemic: The Global Challenge, Advances in Experimental Medicine and Biology (2021)
11. Health and Art (Heart): Integrating Science and Art to Fight Covid-19, Advances in Experimental Medicine and Biology (2021)
15. Covid-19 and Its Global Economic Impact, Advances in Experimental Medicine and Biology (2021)
16. Covid-19 in Patients With Cancer, Advances in Experimental Medicine and Biology (2021)
18. Coronavirus: Pure Infectious Disease or Genetic Predisposition, Advances in Experimental Medicine and Biology (2021)
21. Nutrition and Immunity in Covid-19, Advances in Experimental Medicine and Biology (2021)
22. The Epidemiologic Aspects of Covid-19 Outbreak: Spreading Beyond Expectations, Advances in Experimental Medicine and Biology (2021)
24. Microfluidic Devices for Detection of Rna Viruses, Reviews in Medical Virology (2021)
27. Interdisciplinary Approaches to Covid-19, Advances in Experimental Medicine and Biology (2021)
29. Covid-19 Infection and Stroke Risk, Reviews in the Neurosciences (2021)
30. Geriatrics and Covid-19, Advances in Experimental Medicine and Biology (2021)
43. Covid-19: Neuroimaging Features of a Pandemic, Journal of Neuroimaging (2021)
44. Sars-Cov-2 and Acute Cerebrovascular Events: An Overview, Journal of Clinical Medicine (2021)
48. Covid-19: A Trigger of Autoimmune Diseases, Cell Biology International (2023)
50. Autoimmune Complications of Covid-19, Journal of Medical Virology (2022)